訊映 4155
Listed · Biotechnology and medical care16.9▼-0.6 (-3.43%)After close
- Prev close
- 17.5
- Volume (shares)
- 1,190,500
- Data time
- 2026-11-11 13:30:00
- Open
- 17.25
- High
- 17.95
- Low
- 16.50
- Prev close
- 17.50
- Volume (lots)
- 1,191
- Turnover
- 0.20 億
- P/E
- 9.8
- Cash yield
- 1.78%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 29.86% | 31.96% | 27.62% | 34.90% | 23.36% | 25.19% | 25.39% | 6.10% |
| Operating margin | 11.85% | 15.66% | 16.74% | 13.68% | -5.16% | 5.21% | 8.28% | -4.75% |
| Net margin | 11.25% | 16.56% | 17.52% | 22.76% | -17.92% | 6.81% | 10.87% | -4.84% |
| ROE (TTM) | 9.90% | 4.52% | 3.29% | 2.80% | -1.68% | 3.37% | 3.84% | 0.96% |
| ROA (TTM) | 6.74% | 3.44% | 2.57% | 2.29% | -0.69% | 2.75% | 3.14% | 0.89% |
| EPS, quarter (TWD) | 0.35 | 0.39 | 0.38 | 0.60 | -0.57 | 0.17 | 0.28 | -0.17 |
| EPS, TTM (TWD) | 1.72 | 0.80 | 0.58 | 0.48 | -0.29 | 0.58 | 0.66 | 0.13 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-09 | 2.2 | 10.00% | 59.99% | 13.9 | 13.95% |
| 2026-08 | 2.0 | 29.08% | 49.35% | 11.7 | 8.19% |
| 2026-07 | 1.5 | -11.47% | 33.81% | 9.8 | 2.47% |
| 2026-06 | 1.7 | 23.99% | 22.92% | 8.2 | -1.80% |
| 2026-05 | 1.4 | 9.46% | -2.96% | 6.5 | -6.78% |
| 2026-04 | 1.3 | -13.01% | -9.39% | 5.1 | -7.77% |
| 2026-03 | 1.5 | 38.02% | -10.39% | 3.8 | -7.22% |
| 2026-02 | 1.1 | -19.43% | 10.83% | 2.4 | -5.14% |
| 2026-01 | 1.3 | 35.36% | -15.01% | 1.3 | -15.01% |
| 2025-12 | 1.0 | -13.90% | -40.55% | 15.6 | -7.10% |
| 2025-11 | 1.1 | -11.99% | -8.01% | 14.6 | -3.48% |
| 2025-10 | 1.3 | -5.49% | -11.37% | 13.5 | -3.08% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.4 | 3.8 | 3.4 | 3.8 | 4.3 | 4.1 | 4.2 | 4.6 |
| Cost of revenue | 3.1 | 2.6 | 2.4 | 2.5 | 3.3 | 3.1 | 3.1 | 4.3 |
| Gross profit | 1.3 | 1.2 | 0.9 | 1.3 | 1.0 | 1.0 | 1.1 | 0.3 |
| Operating expenses | 0.8 | 0.6 | 0.4 | 0.8 | 1.2 | 0.8 | 0.8 | 0.5 |
| Operating income | 0.5 | 0.6 | 0.6 | 0.5 | -0.2 | 0.2 | 0.3 | -0.2 |
| Non-operating items | 0.1 | 0.1 | 0.1 | 0.3 | -0.7 | 0.2 | 0.2 | -0.1 |
| Pre-tax income | 0.6 | 0.7 | 0.7 | 0.8 | -0.9 | 0.4 | 0.6 | -0.3 |
| Income tax | 0.1 | 0.1 | 0.1 | -0.0 | -0.1 | 0.1 | 0.1 | -0.1 |
| Continuing operations | 0.5 | 0.6 | 0.6 | 0.9 | -0.8 | 0.3 | 0.5 | -0.2 |
| Net income | 0.5 | 0.6 | 0.6 | 0.9 | -0.8 | 0.3 | 0.5 | -0.2 |
| Net income to parent | 0.5 | 0.6 | 0.5 | 0.9 | -0.8 | 0.2 | 0.4 | -0.2 |
| Net income to NCI | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Other comprehensive income | -0.0 | -0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.0 |
| Total comprehensive income | 0.5 | 0.6 | 0.6 | 0.9 | -0.9 | 0.3 | 0.5 | -0.2 |
| EPS (TWD) | 0.35 | 0.39 | 0.38 | 0.60 | -0.57 | 0.17 | 0.28 | -0.17 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 13.7 | 12.7 | 12.5 | 13.9 | 12.4 | 15.0 | 14.7 | 13.1 |
| Non-current assets | 26.2 | 26.2 | 26.0 | 25.0 | 24.3 | 23.2 | 22.2 | 21.2 |
| Total assets | 39.9 | 38.9 | 38.5 | 38.9 | 36.7 | 38.2 | 37.0 | 34.3 |
| Current liabilities | 5.7 | 5.1 | 5.5 | 7.7 | 6.9 | 7.9 | 7.4 | 7.1 |
| Non-current liabilities | 8.5 | 7.9 | 7.3 | 6.0 | 5.4 | 4.8 | 3.8 | 2.7 |
| Total liabilities | 14.2 | 13.0 | 12.7 | 13.7 | 12.2 | 12.6 | 11.3 | 9.7 |
| Share capital | 14.5 | 14.5 | 14.5 | 14.6 | 14.7 | 14.7 | 14.7 | 14.7 |
| Capital surplus | 8.7 | 8.9 | 8.9 | 8.9 | 8.9 | 8.9 | 8.9 | 8.9 |
| Retained earnings | 3.2 | 2.8 | 2.6 | 2.1 | 1.3 | 2.3 | 2.5 | 2.1 |
| Other equity | -0.7 | -0.8 | -0.8 | -0.9 | -0.9 | -1.1 | -1.2 | -1.2 |
| Treasury stock | -0.6 | — | 0.0 | -0.1 | -0.2 | — | — | — |
| Equity to parent | 25.2 | 25.3 | 25.1 | 24.6 | 23.8 | 24.8 | 24.9 | 24.5 |
| Non-controlling interests | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.1 |
| Total equity | 25.7 | 25.9 | 25.8 | 25.2 | 24.4 | 25.5 | 25.7 | 24.6 |
| Book value per share (TWD) | 17.89 | 17.45 | 17.35 | 16.92 | 16.30 | 16.86 | 16.95 | 16.64 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.3 | 0.6 | 2.5 | 0.5 | -0.2 | 0.4 | 0.3 | -0.9 |
| Investing cash flow | -0.4 | -0.5 | -0.8 | -0.5 | -1.2 | -1.4 | -0.6 | -1.8 |
| Financing cash flow | -0.3 | -0.1 | -1.7 | 1.4 | 0.1 | 1.3 | 1.3 | 0.9 |
| FX effect | 0.0 | -0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.0 | 0.0 |
| Net change in cash | 0.6 | -0.1 | 0.1 | 1.4 | -1.4 | 0.2 | 1.0 | -1.8 |
| Cash, beginning | 3.1 | 3.1 | 2.8 | 2.8 | 2.8 | 2.8 | 3.2 | 3.2 |
| Cash, ending | 3.7 | 3.1 | 3.1 | 3.0 | 1.7 | 3.0 | 2.8 | 1.8 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 240.00% | — | — | — | — | — | — | — |
| Debt ratio | 35.54% | 33.38% | 33.08% | 35.24% | 33.38% | 33.13% | 30.54% | 28.39% |
| Equity ratio | 64.46% | 66.62% | 66.92% | 64.76% | 66.62% | 66.87% | 69.46% | 71.61% |
| Equity multiplier | 1.55 | 1.50 | 1.49 | 1.54 | 1.50 | 1.50 | 1.44 | 1.40 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.40 | 0.40 | 0.41 | 0.45 | 0.48 | 0.50 | 0.49 | 0.46 |
| Equity turnover | 0.61 | 0.59 | 0.61 | 0.66 | 0.70 | 0.70 | 0.67 | 0.63 |
Source: MOPS. For reference only; not investment advice.